Immune responses to Schistosoma haematobium infection

Parasite Immunology

Volumn 36, Issue 9, 2014, Pages 428-438

  Odegaard, J I ^a   Hsieh, M H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immune modulation; Immunoepidemiology; Schistosoma haematobium; Schistosoma spp; Schistosomiasis; Urogenital

Indexed keywords

ADAPTIVE IMMUNITY; B LYMPHOCYTE; BASOPHIL; DENDRITIC CELL; EOSINOPHIL; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MACROPHAGE; MAST CELL; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARASITE IMMUNITY; REVIEW; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; T LYMPHOCYTE; UROGENITAL TRACT INFECTION; ANIMAL; IMMUNOLOGY; PARASITOLOGY;

ANIMALS; HUMANS; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA;

EID: 84908272302     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12084     Document Type: Review

References (107)

1. World Health Organization, The Control of Schistosomiasis. Report of a WHO Expert Committee. Technical Report Series no. 728. Geneva, WHO, 1985.
2. Strickland GT & Ramirez BL. Schistosomiasis. In: Strickland GT, (ed): Hunters Tropical Medicine and Emerging Infectious Diseases. Philadelphia, W.B. Saunders Company. 2000: 804-832.
3. King CH. Health metrics for helminthic infections. Adv Parasitol 2010; 73: 51-69.
4. Gryseels B, Polman K, Clerinx J & Kestens L. Human schistosomiasis. Lancet 2006; 368: 1106-1118.
5. Loker ES. A comparative study of the lifehistories of mammalian schistosomes. Parasitology 1983; 2: 343-369.
6. Rheinberg CE, Moné H, Caffrey CR, Imbert-Establet D, Jourdane J, Ruppel A. Schistosoma haematobium, S. intercalatum, S. japonicum, S. mansoni, and S. rodhaini in mice: relationship between patterns of lung migration by schistosomula and perfusion recovery of adult worms. Parasitol Res 1998; 84: 338-342.
7. Fu C-L, Odegaard JI, Herbert DR & Hsieh MH. A novel mouse model of Schistosoma haematobium egg-induced immunopathology. PLoS Pathog 2012; 8: e1002605.
8. Rinaldi G, Okatcha TI, Popratiloff A, et al. Genetic manipulation of Schistosoma haematobium, the neglected schistosome. PLoS Negl Trop Dis 2011; 5: e1348.
9. Young ND, Jex AR, Li B, et al. Wholegenome sequence of Schistosoma haematobium. Nat Genet 2012; 44: 221-225.
10. Beaver Jung RC & Cupp EWPC. Clinical Parasitology. Philadelphia, PA, Lea and Febiger. 1984.
11. El Ridi R, Ismail S, Gaafar T & El Demellawy M. Differential responsiveness of humans with early-stage schistosomiasis haematobium to Schistosoma haematobium soluble adult-worm and egg antigens. Parasitol Res 1997; 83: 471-477.
12. Gaafar T, Helmy M, Ismail S, Afifi A, Guirguis N, el Ridi R. Identification of the Schistosoma haematobium soluble egg antigens inducing antibody production and/or T cell proliferation in humans. J Egypt Soc Parasitol 1992; 22: 441-451.
13. Gaafar T, Ismail S, Helmy M, Afifi A, Guirguis N, el Ridi R. Identification of Schistosoma haematobium soluble egg antigens that elicit human granuloma formation in vitro. Parasitol Res 1993; 79: 103-108.
14. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ & Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991; 349: 243- 245.
15. Cheever AW, Kamel IA, Elwi AM, Mosimann JE & Danner R. Schistosoma mansoni and S. haematobium infections in Egypt. II. Quantitative parasitological findings at necropsy. Am J Trop Med Hyg 1977; 26: 702-716.
16. Cheever AW, Kamel IA, Elwi AM, Mosimann JE, Danner R, Sippel JE. Schistosoma mansoni and S. haematobium infections in Egypt. III. Extrahepatic pathology. Am J Trop Med Hyg 1978; 27: 55-75.
17. Ghoneim I, Rabets J & Mawhorter S. Campbell-Walsh urology/editor-in-chief, Alan J. Wein; [editors, Louis R. Kavoussi... et al.]. In: Wein AJ, Kavoussi LR & Campbell MF (eds): Campbell-Walsh Urology. Philadelphia, PA: Elsevier Saunders. 2011: p. 4 v. (xxxvii, 3753, 95 p.).
18. Sadun EH, Von Lichtenberg F, Cheever AW, Erickson DG & Hickman RL. Experimental infection with Schistosoma haematobium in chimpanzees. Am J Trop Med Hyg 1970; 19: 427-458.
19. Von Lichtenberg F, Edington GM, Nwabuebo I, Taylor JR & Smith JH. Pathologic effects of schistomiasis in Ibadan Western State of Nigeria. II. Pathogenesis of lesions of the bladder and ureters. Am J Trop Med Hyg 1971; 20: 244-254.
20. Smith JH, Torky H, Kelada AS & Farid Z. Schistosomal polyposis of the urinary bladder. Am J Trop Med Hyg 1977; 26: 85-88.
21. Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol 2007; 85: 148-154.
22. Herbert DR, Holscher C, Mohrs M, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004; 20: 623-635.
23. Chu D, Du M, Hu X, Wu Q & Shen J. Paeoniflorin attenuates schistosomiasis japonica-associated liver fibrosis through inhibiting alternative activation of macrophages. Parasitology 2011; 138: 1259-1271.
24. Burke ML, McManus DP, Ramm GA, et al. Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis. PLoS Negl Trop Dis 2010; 4: e598.
25. Hams E, Aviello G & Fallon PG. The Schistosoma granuloma: friend or foe? Front Immunol 2013; 4: 89.
26. Ray D, Nelson TA, Fu C-L, et al. Transcriptional profiling of the bladder in urogenital schistosomiasis reveals pathways of inflammatory fibrosis and urothelial compromise. PLoS Negl Trop Dis 2012; 6: e1912.
27. Eltoum IA, Suliaman SM, Ismail BM, Ismail AI, Ali MM, Homeida MM. Evaluation of eosinophiluria in the diagnosis of schistosomiasis hematobium: a field-based study. Am J Trop Med Hyg 1992; 46: 732-736.
28. Reimert CM, Mshinda HM, Hatz CF, et al. Quantitative assessment of eosinophiluria in Schistosoma haematobium infections: a new marker of infection and bladder morbidity. Am J Trop Med Hyg 2000; 62: 19-28.
29. Verwaerde C, Joseph M, Capron M, et al. Functional properties of a rat monoclonal IgE antibody specific for Schistosoma mansoni. J Immunol 1987; 138: 4441-4446.
30. Rousseaux-Prevost R, Capron M, Bazin H & Capron A. IgE in experimental schistosomiasis. II. Quantitative determination of specific IgE antibodies against S. mansoni: a follow-up study of two strains of infected rats. Correlation with protective immunity. Immunology 1978; 35: 33-39.
31. Gounni AS, Lamkhioued B, Ochiai K, et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994; 367: 183-186.
32. Molofsky AB, Nussbaum JC, Liang H-E, et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med 2013; 210: 535-549.
33. Heredia JE, Mukundan L, Chen FM, et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 2013; 153: 376-388.
34. Reiman RM, Thompson RW, Feng CG, et al. Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun 2006; 74: 1471- 1479.
35. Swartz JM, Dyer KD, Cheever AW, et al. Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood 2006; 108: 2420-2427.
36. Phythian-Adams AT, Cook PC, Lundie RJ, et al. CD11c depletion severely disrupts Th2 induction and development in vivo. J Exp Med 2010; 207: 2089-2096.
37. Kane CM, Cervi L, Sun J, et al. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol 2004; 173: 7454- 7461.
38. Van Liempt E, van Vliet SJ, Engering A, et al. Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol Immunol 2007; 44: 2605- 2615.
39. Perona-Wright G, Jenkins SJ & MacDonald AS. Dendritic cell activation and function in response to Schistosoma mansoni. Int J Parasitol 2006; 36: 711-721.
40. MacDonald AS, Straw AD, Dalton NM & Pearce EJ. Cutting edge: Th2 response induction by dendritic cells: a role for CD40. J Immunol 2002; 168: 537-540.
41. Blázquez AB & Berin MC. Gastrointestinal dendritic cells promote Th2 skewing via OX40L. J Immunol 2008; 180: 4441-4450.
42. Jenkins SJ & Mountford AP. Dendritic cells activated with products released by schistosome larvae drive Th2-type immune responses, which can be inhibited by manipulation of CD40 costimulation. Infect Immun 2005; 73: 395-402.
43. Everts B, Hussaarts L, Driessen NN, et al. Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J Exp Med 2012; 209: 1753-1767.
44. Dunne DW, Jones FM & Doenhoff MJ. The purification, characterization, serological activity and hepatotoxic properties of two cationic glycoproteins (alpha 1 and omega 1) from Schistosoma mansoni eggs. Parasitology 1991; 2: 225-236.
45. Remick DG, Chensue SW, Hiserodt JC, Higashi GI & Kunkel SL. Flow-cytometric evaluation of lymphocyte subpopulations in synchronously developing Schistosoma mansoni egg and Sephadex bead pulmonary granulomas. Amer J Pathol 1988; 131: 298- 307.
46. Asseman C, Pancré V, Quatennens B & Auriault C. Schistosoma mansoni-infected mice show augmented hepatic fibrosis and selective inhibition of liver cytokine production after treatment with anti-NK1.1 antibodies. Immunol Lett 1996; 54: 11-20.
47. Hou X, Yu F, Man S, et al. Negative regulation of Schistosoma japonicum egg-induced liver fibrosis by natural killer cells. PLoS Negl Trop Dis 2012; 6: e1456.
48. Hashimoto A, Pincelli C, Fujioka A, Fukuyama K & Epstein WL. Relationship between NK cells and granulomatous inflammation in mice. J Clin Lab Immunol 1990; 33: 41-47.
49. Gao B & Radaeva S. Natural killer and natural killer T cells in liver fibrosis. Biochim Biophys Acta 2013; 1832: 1061- 1069.
50. Niel G, Sainte-Laudy J, Carme B, et al. The comparative value of the human basophil degranulation test and classical serology (immunofluorescence, haemagglutination, electrosyneresis, Vogel and Minnings Test) in the diagnosis of bilharzioses due to Schistosoma mansoni and Schistosoma haematob. Ann Biol Clin 1982; 40: 573-577.
51. Schramm G, Mohrs K, Wodrich M, et al. Cutting edge: IPSE/alpha-1, a glycoprotein from Schistosoma mansoni eggs, induces IgEdependent, antigen-independent IL-4 production by murine basophils in vivo. J Immunol 2007; 178: 6023-6027.
52. Sullivan BM, Liang H-E, Bando JK, et al. Genetic analysis of basophil function in vivo. Nat Immunol 2011; 12: 527-535.
53. Ganley-Leal LM, Mwinzi PNM, Cetre-Sossah CB, et al. Higher percentages of circulating mast cell precursors correlate with susceptibility to reinfection with Schistosoma mansoni. Am J Trop Med Hyg 2006; 75: 1053-1057.
54. Chan CY, St John AL, Abraham SN & St. John AL. Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity 2013; 38: 1-11.
55. Cheng Y, Song W, Liu W, et al. The effects of T cell deficiency on the development of worms and granuloma formation in mice infected with Schistosoma japonicum. Parasitol Res 2008; 102: 1129-1134.
56. Byram JE & von Lichtenberg F. Altered schistosome granuloma formation in nude mice. Am J Trop Med Hyg 1977; 26: 944- 956.
57. Kouriba B, Chevillard C, Bream JH, et al. Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections. J Immunol 2005; 174: 6274-6281.
58. Isnard A, Kouriba B, Doumbo O & Chevillard C. Association of rs7719175, located in the IL13 gene promoter, with Schistosoma haematobium infection levels and identification of a susceptibility haplotype. Genes Immun 2011; 12: 31-39.
59. He H, Isnard A, Kouriba B, et al. A STAT6 gene polymorphism is associated with high infection levels in urinary schistosomiasis. Genes Immun 2008; 9: 195-206.
60. Yap G, Cheever A, Caspar P, Jankovic D & Sher A. Unimpaired down-modulation of the hepatic granulomatous response in CD8 T-cell- and gamma interferon-deficient mice chronically infected with Schistosoma mansoni. Infect Immun 1997; 65: 2583-2586.
61. Chensue SW, Warmington K, Ruth JH, Lukacs N & Kunkel SL. Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks. J Immunol 1997; 159: 3565-3573.
62. Wynn TA, Morawetz R, Scharton-Kersten T, et al. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J Immunol 1997; 159: 5014-5023.
63. Burke ML, Jones MK, Gobert GN, Li YS, Ellis MK, McManus DP. Immunopathogenesis of human schistosomiasis. Parasite Immunol 2009; 31: 163-176.
64. Wahl SM, Frazier-Jessen M, Jin WW, Kopp JB, Sher A, Cheever AW. Cytokine regulation of schistosome-induced granuloma and fibrosis. Kidney Int 1997; 51: 1370-1375.
65. Okano M, Satoskar AR, Nishizaki K, Abe M & Harn DA. Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. J Immunol 1999; 163: 6712-6717.
66. Lundy SK & Boros DL. Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect Immun 2002; 70: 812-819.
67. Reis EAG, Azevedo TM, McBride AJA, Harn DA & Reis MG. Naïve donor responses to Schistosoma mansoni soluble egg antigens. Scand J Immunol 2007; 66: 662-670.
68. Teixeira-Carvalho A, Martins-Filho OA, Peruhype-Magalhães V, et al. Cytokines, chemokine receptors, CD4+CD25HIGH+ T-cells and clinical forms of human schistosomiasis. Acta Trop 2008; 108: 139-149.
69. Vella AT & Pearce EJ. CD4 + Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. J Immunol 1992; 148: 2283-2290.
70. Isnard A & Chevillard C. Recent advances in the characterization of genetic factors involved in human susceptibility to infection by schistosomiasis. Curr Genomics 2008; 9: 290-300.
71. Maizels RM. Parasite immunomodulation and polymorphisms of the immune system. J Biol 2009; 8: 62.
72. Mallevaey T, Fontaine J, Breuilh L, et al. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis. Infect Immun 2007; 75: 2171-2180.
73. Mallevaey T, Zanetta JP, Faveeuw C, et al. Activation of invariant NKT cells by the helminth parasite Schistosoma mansoni. J Immunol 2006; 176: 2476-2485.
74. Ji F, Liu Z, Cao J, Li N, Liu Z, et al. B cell response is required for granuloma formation in the early infection of Schistosoma japonicum. PLoS ONE 2008; 3: e1724.
75. Nash TE. Antibody response to a polysaccharide antigen present in the schistosome gut. I. Sensitivity and specificity. Am J Trop Med Hyg 1978; 27: 939-943.
76. Grogan JL, Kremsner PG, van Dam GJ, Deelder AM & Yazdanbakhsh M. Anti-schistosome IgG4 and IgE at 2 years after chemotherapy: infected versus uninfected individuals. J Infect Dis 1997; 176: 1344- 1350.
77. Iskander R, Das PK & Aalberse RC. IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Immunol 1981; 66: 200-207.
78. Naus CW, van Dam GJ, Kremsner PG, Krijger FW & Deelder AM. Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children. Clin Infect Dis 1998; 26: 1142-1147.
79. Mutapi F, Burchmore R, Mduluza T, Midzi N, Turner CMR, Maizels RM. Age-related and infection intensity-related shifts in antibody recognition of defined protein antigens in a schistosome-exposed population. J Infect Dis 2008; 198: 167-175.
80. Rauterberg J, Voss B, Pott G & Gerlach U. Connective tissue components of the normal and fibrotic liver. I. Structure, local distribution and metabolism of connective tissue components in the normal liver and changes in chronic liver diseases. Klinische Wochenschrift 1981; 59: 767-779.
81. Von Lichtenberg F. Schistosomiasis as a worldwide problem: pathology. J Toxicol Environ Health 1975; 1: 175-184.
82. Abdel-Wahab MF, Ramzy I, Esmat G, El Kafass H & Strickland GT. Ultrasound for detecting Schistosoma haematobium urinary tract complications: comparison with radiographic procedures. J Urol 1992; 148: 346-350.
83. Gelfand M, Weinberg RW & Castle WM. Relation between carcinoma of the bladder and infestation with Schistosoma haematobium. Lancet 1967; 1: 1249-1251.
84. Brand KG. Schistosomiasis--cancer: etiological considerations. A review. Acta Trop 1979; 36: 203-214.
85. Kjetland EF, Kurewa EN, Ndhlovu PD, et al. Female genital schistosomiasis--a differential diagnosis to sexually transmitted disease: genital itch and vaginal discharge as indicators of genital Schistosoma haematobium morbidity in a cross-sectional study in endemic rural Zimbabwe. Trop Med Int Health 2008; 13: 1509-1517.
86. Jourdan PM, Roald B, Poggensee G, Gundersen SG & Kjetland EF. Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection. PLoS Negl Trop Dis 2011; 5: e1170.
87. Kjetland EF, Mduluza T, Ndhlovu PD, et al. Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel. Trans R Soc Trop Med Hyg 2006; 100: 740-752.
88. Kjetland EF, Leutscher PDC & Ndhlovu PD. A review of female genital schistosomiasis. Trends Parasitol 2012; 28: 59-66.
89. Kjetland EF, Ndhlovu PD, Mduluza T, et al. Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women. Am J Trop Med Hyg 2005; 72: 311-319.
90. Helling-Giese G, Sjaastad A, Poggensee G, et al. Female genital schistosomiasis (FGS): relationship between gynecological and histopathological findings. Acta Trop 1996; 62: 257-267.
91. Hegertun IEA, Sulheim Gundersen KM, Kleppa E, et al. S. haematobium as a common cause of genital morbidity in girls: a cross-sectional study of children in South Africa. PLoS Negl Trop Dis 2013; 7: e2104.
92. Corachan M, Valls ME, Gascon J, Almeda J & Vilana R. Hematospermia: a new etiology of clinical interest. Am J Trop Med Hyg 1994; 50: 580-584.
93. Farid Bassily S, Schulert AR, Zeind AS, McConnell E, Abdel Wahab MF. Urinary blood loss in Schistosoma haematobium infection in Egyptian farmers. Trans R Soc Trop Med Hyg 1968; 62: 496-500.
94. Tatala SR, Kihamia CM, Kyungu LH & Svanberg U. Risk factors for anaemia in schoolchildren in Tanga Region, Tanzania. Tanzan J Health Res 2008; 10: 189-202.
95. The Partnership for Child Development. The health and nutritional status of schoolchildren in Africa: evidence from schoolbased health programmes in Ghana and Tanzania. The Partnership for Child Development. Trans R Soc Trop Med Hyg 1998; 92: 254-261.
96. Nmorsi OP, Kwandu UN & Ebiaguanye LM. Schistosoma haematobium and urinary tract pathogens co-infections in a rural community of Edo State, Nigeria. J Commun Dis 2007; 39: 85-90.
97. Kassim OO & Stek M Jr. Bacteriuria and hematuria in infections due to Schistosoma haematobium. J Infect Dis 1983; 147: 960.
98. Wilkins HA. Schistosoma haematobium in a Gambian community. III. The prevalence of bacteriuria and of hypertension. Ann Trop Med Parasitol 1977; 71: 179-186.
99. Courtin D, Djilali-Saïah A, Milet J, et al. Schistosoma haematobium infection affects Plasmodium falciparum-specific IgG responses associated with protection against malaria. Parasite Immunol 2011; 33: 124- 131.
100. Diallo TO, Remoue F, Schacht AM, et al. Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol 2004; 26: 365-369.
101. Cardoso LS, Oliveira SC & Araujo MI. Schistosoma mansoni antigens as modulators of the allergic inflammatory response in asthma. Endocr Metab Immune Disord Drug Targets 2012; 12: 24-32.
102. Medeiros M, Figueiredo JP, Almeida MC, et al. Schistosoma mansoni infection is associated with a reduced course of asthma. J Allergy Clin Immunol 2003; 111: 947-951.
103. Araujo MI, Lopes AA, Medeiros M, et al. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch Allergy Immunol 2000; 123: 145-148.
104. Araújo MI, Hoppe BS, Medeiros M & Carvalho EM. Schistosoma mansoni infection modulates the immune response against allergic and auto-immune diseases. Mem Inst Oswaldo Cruz 2004; 99: 27-32.
105. Lynch NR, Hagel I, Perez M, Di Prisco MC, Lopez R, Alvarez N. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. Current Genomics 1993; 9: 290-300.
106. Grant AV, Araujo MI, Ponte EV, et al. Polymorphisms in IL10 are associated with total Immunoglobulin E levels and Schistosoma mansoni infection intensity in a Brazilian population. Genes Immun 2011; 12: 46-50.
107. Larson D, Hubner MP, Torrero MN, et al. Chronic helminth infection reduces basophil responsiveness in an IL-10-dependent manner. J Immunol 2012; 188: 4188-4199.